Income Statement Resverlogix Corp.

Stocks

RVX

CA76128M1086

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 09:54:11 2026-06-17 EDT			5-day change	1st Jan Change
0.1000 ^CAD	+5.26%		0.00%	-

05-15	Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-11	Resverlogix Corp. Announces One-Year Extension of USD 6.0 Million Secured Debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd	CI

d4efa6aac2879c97289adf6c75962.XDgdIEpjs_okY7iSZlbxLFbJFk7zfAR9wFDBDsbGQ8c.A2dHUQ4q8pdqE_bwFw66SGWaXTShL3U7jiO3O6H_FI0pXS1NGAffiVQ2yw

Published financial data: RESVERLOGIX CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	11.39M	7.2M	3.02M	1.8M	1.96M
R&D Expenses	4.55M	4.23M	2.16M	2.8M	2.95M
Other Operating Expenses, Total	15.94M	11.43M	5.18M	4.6M	4.91M
Operating Income	-15.94M	-11.43M	-5.18M	-4.6M	-4.91M
Interest Expense, Total	-700K	-1.64M	-1.81M	-3.12M	-4.2M
Net Interest Expenses	-700K	-1.64M	-1.81M	-3.12M	-4.2M
Currency Exchange Gains (Loss)	-81K	29K	-19K	51K	-45K
Other Non Operating Income (Expenses)	4.73M	3.36M	721K	564K	-110K
EBT, Excl. Unusual Items	-11.99M	-9.68M	-6.28M	-7.1M	-9.26M
Asset Writedown	-	-1.28M	-1.03M	-	-155K
Other Unusual Items	-12.77M	7.37M	-9.41M	-520K	1.66M
EBT, Incl. Unusual Items	-24.76M	-3.59M	-16.73M	-7.62M	-7.76M
Income Tax Expense	12K	18K	15K	14K	11K
Earnings From Continuing Operations	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Net Income to Company	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Net Income - (IS)	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Net Income to Common Incl Extra Items	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Net Income to Common Excl. Extra Items	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Per Share Items
Net EPS - Basic	-0.1	-0.01	-0.06	-0.03	-0.03
Basic EPS - Continuing Operations	-0.1	-0.01	-0.06	-0.03	-0.03
Basic Weighted Average Shares Outstanding	240M	266M	270M	277M	285M
Net EPS - Diluted	-0.1	-0.01	-0.06	-0.03	-0.03
Diluted EPS - Continuing Operations	-0.1	-0.01	-0.06	-0.03	-0.03
Diluted Weighted Average Shares Outstanding	240M	266M	270M	277M	285M
Normalized Basic EPS	-0.03	-0.02	-0.01	-0.02	-0.02
Normalized Diluted EPS	-0.03	-0.02	-0.01	-0.02	-0.02
Supplemental Items
EBITDA	-15.52M	-10.96M	-4.82M	-4.25M	-4.48M
EBITA	-15.6M	-11.04M	-4.89M	-4.25M	-4.48M
EBIT	-15.94M	-11.43M	-5.18M	-4.6M	-4.91M
Effective Tax Rate - (Ratio)	-0.05	-0.5	-0.09	-0.18	-0.14
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	12K	18K	15K	14K	11K
Normalized Net Income	-7.5M	-6.05M	-3.93M	-4.44M	-5.79M
Interest on Long-Term Debt	800K	1.64M	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	1.8M	1.96M
Research And Development Expense From Footnotes	4.62M	5.62M	3.25M	2.86M	3.15M
Stock-Based Comp., R&D Exp. (Total)	783K	705K	340K	-	40K
Stock-Based Comp., G&A Exp. (Total)	-	-	-	304K	428K
Stock-Based Comp., SG&A Exp. (Total)	1.84M	1.69M	909K	-	-
Total Stock-Based Compensation	2.62M	2.39M	1.25M	304K	468K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6K	40K	5K	99K	108K
Total Cash And Short Term Investments	6K	40K	5K	99K	108K
Other Receivables	310K	323K	58K	241K	912K
Total Receivables	310K	323K	58K	241K	912K
Inventory	2.45M	2.37M	300K	996K	435K
Prepaid Expenses	167K	146K	149K	162K	120K
Other Current Assets, Total	17K	8K	6K	40K	31K
Total Current Assets	2.95M	2.89M	518K	1.54M	1.61M
Gross Property Plant And Equipment	3.79M	2.77M	1M	-	-
Accumulated Depreciation	-2.75M	-2.34M	-1M	-	-
Net Property Plant And Equipment	1.04M	426K	0	-	9K
Other Intangibles, Total	3.43M	2.2M	2.36M	2.49M	2.59M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	2.56M	2.6M	3.64M	3.32M	3.74M
Total Assets	9.98M	8.12M	6.52M	7.34M	7.95M
Liabilities
Accounts Payable, Total	8.7M	14.1M	3.63M	4.3M	5.18M
Accrued Expenses, Total	383K	1.02M	1.88M	1.78M	4.62M
Short-term Borrowings	5.97M	6.05M	17.61M	20M	25.62M
Current Portion of Long-Term Debt	-	-	-	-	8.13M
Current Portion of Leases	632K	437K	44K	42K	44K
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	1.74M	1.13M	3.69M	189K	453K
Total Current Liabilities	17.42M	22.73M	26.86M	26.31M	44.06M
Long-Term Debt	50.7M	43.7M	53.3M	61.93M	52.1M
Long-Term Leases	442K	-	-	-	-
Other Non Current Liabilities	1.29M	962K	837K	837K	753K
Total Liabilities	69.85M	67.4M	80.99M	89.08M	96.91M
Common Stock, Total	327M	331M	334M	335M	335M
Additional Paid In Capital	55.32M	54.98M	54.24M	53.71M	53.94M
Retained Earnings	-442M	-446M	-462M	-470M	-478M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	-59.87M	-59.28M	-74.47M	-81.74M	-88.96M
Total Equity	-59.87M	-59.28M	-74.47M	-81.74M	-88.96M
Total Liabilities And Equity	9.98M	8.12M	6.52M	7.34M	7.95M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	248M	268M	275M	283M	316M
ECS Total Common Shares Outstanding	243M	266M	272M	282M	288M
Book Value / Share	-0.25	-0.22	-0.27	-0.29	-0.31
Tangible Book Value	-63.3M	-61.49M	-76.84M	-84.22M	-91.55M
Tangible Book Value Per Share	-0.26	-0.23	-0.28	-0.3	-0.32
Total Debt	57.74M	50.19M	70.95M	81.97M	85.9M
Net Debt	57.73M	50.15M	70.94M	81.87M	85.79M
Account Code - Inventory Valuation	-	3	3	3	3
Inventories - Others	2.45M	2.37M	300K	996K	435K
Machinery, Total	393K	275K	269K	-	-
Full Time Employees	22	19	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-24.77M	-3.61M	-16.74M	-7.64M	-7.77M
Depreciation & Amortization - CF	761K	613K	426K	-	-
Amortization of Goodwill and Intangible Assets - (CF)	345K	394K	290K	348K	430K
Depreciation & Amortization, Total	1.11M	1.01M	716K	348K	430K
Amortization of Deferred Charges, Total - (CF)	300K	300K	200K	-	-
Asset Writedown & Restructuring Costs	-	1.28M	1.03M	-	155K
Stock-Based Compensation (CF)	2.62M	2.39M	1.25M	304K	468K
Other Operating Activities, Total	8.07M	-9.64M	10.32M	3.07M	2.66M
Change In Inventories	-72K	-8K	-	-377K	136K
Change In Accounts Payable	3.95M	4.67M	496K	590K	880K
Change in Unearned Revenues	-	-	-	-	-
Change In Deferred Taxes	-4K	-102K	118K	10K	-2K
Change in Other Net Operating Assets	775K	175K	-1K	-194K	-618K
Cash from Operations	-8.02M	-3.54M	-2.61M	-3.89M	-3.66M
Capital Expenditure	-	-	-	-	-9K
Sale (Purchase) of Intangible assets	-877K	-450K	-448K	-472K	-687K
Other Investing Activities, Total	44K	-23K	-68K	95K	47K
Cash from Investing	-833K	-473K	-516K	-377K	-649K
Short Term Debt Issued, Total	6.08M	441K	-	4.38M	4.32M
Total Debt Issued	6.08M	441K	-	4.38M	4.32M
Short Term Debt Repaid, Total	-114K	-355K	-	-	-
Long-Term Debt Repaid, Total	-757K	-639K	-406K	-	-
Total Debt Repaid	-871K	-994K	-406K	-	-
Issuance of Common Stock	4.02M	1.52M	172K	-	-
Other Financing Activities, Total	-419K	3.1M	3.33M	-19K	-
Cash from Financing	8.81M	4.06M	3.09M	4.36M	4.32M
Foreign Exchange Rate Adjustments	-31K	-15K	-	-2K	2K
Net Change in Cash	-81K	34K	-35K	94K	9K
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	9K	11K	-15K	-14K	14K
Levered Free Cash Flow	-8.58M	600K	2.75M	-5.34M	-1.56M
Unlevered Free Cash Flow	-8.44M	1.32M	3.68M	-3.4M	1.06M
Change In Net Working Capital	1.33M	-5.52M	-5.4M	700K	-3.93M
Net Debt Issued / Repaid	5.21M	-553K	-406K	4.38M	4.32M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-96.32	-78.98	-44.23	-41.34	-40.13
Return on Total Capital	805.1	127.38	257.46	4.46K	216.91
Return On Equity %	49.66	6.06	25.03	9.78	9.1
Return on Common Equity	49.66	6.06	25.03	9.78	9.1
Short Term Liquidity
Current Ratio	0.17	0.13	0.02	0.06	0.04
Quick Ratio	0.02	0.02	0	0.01	0.02
Operating Cash Flow to Current Liabilities	-0.46	-0.16	-0.1	-0.15	-0.08
Long Term Solvency
Total Debt/Equity	-96.44	-84.67	-95.27	-100.29	-96.56
Total Debt / Total Capital	-2.71K	-552.16	-2.01K	34.88K	-2.8K
LT Debt/Equity	-85.42	-73.72	-71.57	-75.77	-58.56
Long-Term Debt / Total Capital	-2.4K	-480.75	-1.51K	26.35K	-1.7K
Total Liabilities / Total Assets	699.78	830.51	1.24K	1.21K	1.22K
EBIT / Interest Expense	-22.77	-6.98	-2.87	-1.48	-1.17
EBITDA / Interest Expense	-21.19	-6.37	-2.47	-1.36	-1.07
(EBITDA - Capex) / Interest Expense	-21.19	-6.37	-2.47	-1.36	-1.07
Total Debt / EBITDA	-3.89	-4.81	-15.9	-19.28	-19.18
Net Debt / EBITDA	-3.89	-4.81	-15.9	-19.25	-19.15
Total Debt / (EBITDA - Capex)	-3.89	-4.81	-15.9	-19.28	-19.14
Net Debt / (EBITDA - Capex)	-3.89	-4.81	-15.9	-19.25	-19.12
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	9.27	-29.34	-56.02	-11.82	5.34
EBITA, 1 Yr. Growth %	9.2	-29.21	-55.72	-13.01	5.34
EBIT, 1 Yr. Growth %	9.41	-28.27	-54.71	-11.16	6.72
Earnings From Cont. Operations, 1 Yr. Growth %	-1.11K	-85.43	363.74	-54.39	1.73
Net Income, 1 Yr. Growth %	-1.11K	-85.43	363.74	-54.39	1.73
Normalized Net Income, 1 Yr. Growth %	29.09	-19.26	-32.31	13.02	30.46
Diluted EPS Before Extra, 1 Yr. Growth %	-1.02K	-86.84	337.08	-55.49	-1.32
Inventory, 1 Yr. Growth %	320.03	-3.34	-87.35	232	-56.33
Net Property, Plant and Equip., 1 Yr. Growth %	-28.74	-59	-100	-	-
Total Assets, 1 Yr. Growth %	-6.76	-18.7	-19.67	11.87	8.22
Tangible Book Value, 1 Yr. Growth %	47.92	-2.86	24.97	9.61	8.7
Common Equity, 1 Yr. Growth %	50.07	-0.98	25.63	9.75	8.84
Cash From Operations, 1 Yr. Growth %	82.32	-55.87	-28.02	54.7	-5.79
Capital Expenditures, 1 Yr. Growth %	-	-	-	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-	-106.93	-128.94	774.92	-70.74
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-115.68	-141.91	-754.46	-131.28
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-12.13	-44.25	-37.73	-3.62
EBITA, 2 Yr. CAGR %	-	-12.08	-44.02	-37.94	-4.28
EBIT, 2 Yr. CAGR %	-	-11.41	-43.01	-36.57	-2.63
Earnings From Cont. Operations, 2 Yr. CAGR %	-	21.03	-17.79	45.43	-31.89
Net Income, 2 Yr. CAGR %	-	21.03	-17.79	45.43	-31.89
Normalized Net Income, 2 Yr. CAGR %	-	2.09	-27.62	-12.53	21.43
Diluted EPS Before Extra, 2 Yr. CAGR %	-	10.22	-22.51	39.48	-33.72
Inventory, 2 Yr. CAGR %	-	101.49	-65.03	-35.19	20.42
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-45.95	-	-	-
Total Assets, 2 Yr. CAGR %	-	-12.94	-19.19	-4.87	10.03
Tangible Book Value, 2 Yr. CAGR %	-	19.87	10.18	17.04	9.16
Common Equity, 2 Yr. CAGR %	-	21.9	11.53	17.42	9.29
Cash From Operations, 2 Yr. CAGR %	-	-10.3	-42.93	3.47	20.72
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-43.64	-25.01	60
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-33.97	-37.81	43.07
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-30.23	-35.05	-25.8
EBITA, 3 Yr. CAGR %	-	-	-30.05	-35.16	-25.97
EBIT, 3 Yr. CAGR %	-	-	-29.17	-33.92	-24.56
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	89.39	-32.45	29.1
Net Income, 3 Yr. CAGR %	-	-	89.39	-32.45	29.1
Normalized Net Income, 3 Yr. CAGR %	-	-	-12.22	-16.03	-0.06
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	76.99	-35.58	24.29
Inventory, 3 Yr. CAGR %	-	-	-19.91	-25.95	-43.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-	-72.36
Total Assets, 3 Yr. CAGR %	-	-	-15.24	-9.72	-0.69
Tangible Book Value, 3 Yr. CAGR %	-	-	21.55	9.99	14.19
Common Equity, 3 Yr. CAGR %	-	-	23.13	10.93	14.49
Cash From Operations, 3 Yr. CAGR %	-	-	-15.95	-21.47	0.28
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-14.85	-45.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-26.18	-50.54
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	-20.61
EBITA, 5 Yr. CAGR %	-	-	-	-	-20.7
EBIT, 5 Yr. CAGR %	-	-	-	-	-19.55
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	25.81
Net Income, 5 Yr. CAGR %	-	-	-	-	25.81
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	-0.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	19.48
Inventory, 5 Yr. CAGR %	-	-	-	-	-5.72
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	-63.85
Total Assets, 5 Yr. CAGR %	-	-	-	-	-5.78
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	16.43
Common Equity, 5 Yr. CAGR %	-	-	-	-	17.4
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-3.62
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-